Advances in the pharmacologic treatment of tension-type headache.
Tension-type headache (TTH) is the most prevalent form of primary headache in the general population. We discuss advances in the treatment of TTH. We briefly review nonpharmacologic therapies and then focus on current pharmacologic strategies. For acute treatment, the most common interventions involve the use of simple analgesics and anti-inflammatory medications, often taken by the patient without a prescription. For preventive treatment, amitriptyline is the best-studied drug, but nortriptyline, mirtazapine, tizanidine, the selective serotonin reuptake inhibitors, and other medications can be used. We close by discussing potential future therapies, including calcitonin gene-related peptide receptor antagonism, as well as substance P and the nitric oxide pathways.
Bigal
Marcelo E
ME
Global Director for Scientific Affairs, Merck Research Laboratories, Whitehouse Station, NJ 08889, USA. marcelo_bigal@merck.com
Rapoport
Alan M
AM
Hargreaves
Richard
R
D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends*; D018781:Tension-Type Headache / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology
D004364:Pharmaceutical Preparations